3 Longtime Losers About to See Green?
These 3 biotechs have lost tons of money every year so far in the 21st century. But could profits be on the horizon?
Better Buy: Dynavax Technologies Corp. vs. Geron Corp.
Dynavax Technologies Corp. and Geron Corp. have pending catalysts that could cause their shares to double from current levels. Here's a Foolish look at which company offers the better risk-to-reward profile.
Will Investors Profit from Geron's Road to Recovery?
Geron gets a clinical hold released, but is still a ways away from competing with Incyte's Jakafi.